Adtrinib 200mg Tablet 30's

Adtrinib Tablet is a multikinase inhibitor containing sorafenib, used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer. The medicine is not recommended if you are allergic to sorafenib or other ingredients in the formulation. Contact your doctor immediately if you develop skin rashes, heart problems, chest pain, bleeding problems, high blood pressure, or if you have had or are about to undergo surgery. Use in children and adolescents is not recommended. Patients with diabetes require frequent blood sugar monitoring to determine whether anti-diabetic medication dosage adjustments are necessary to reduce the risk of hypoglycaemia. Your doctor will monitor liver function tests and fluid and electrolyte balance to identify and manage potential side effects promptly.

Advanced renal cell carcinoma Advanced hepatocellular carcinoma Differentiated thyroid carcinoma

Adtrinib Tablet works by inhibiting multiple protein kinases involved in tumour cell proliferation and angiogenesis (the formation of new blood vessels that supply tumours). Specifically, it targets receptors for vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and Raf kinases, which play key roles in cancer development and progression. This stops the growth and spread of the tumour cells to other organs, as well as the formation of blood vessels in the tumour cells.

A healthcare professional in a hospital setting will prescribe the medicine to you. It is not recommended to take this medication with meals that are high in fat since this may reduce Adtrinib Tablet's effectiveness. If you plan to eat one, take the pills at least one hour before or two hours after. Your healthcare professional will decide the dose based on your conditions. Avoid crushing, opening, or dissolving the tablet; swallow it whole with a glass of water. Take the Adtrinib tablet at the same time every day.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common: Nausea Vomiting Fatigue Diarrhoea Alopecia Hand foot skin reaction Gut wall bleeding Serious: gastrointestinal perforation abnormal heart rhythm (QT prolongation) inflammation of the liver breathing or swallowing difficulties Stevens Johnsons Syndrome and toxic epidermal necrolysis Decreased blood flow to the heart Increased risk of bleeding (blood in urine, stool, vomit, cough, etc)

Follow all instructions and dosing recommendations provided by your healthcare provider. Do not take more or less of the medication than prescribed. Report any new or worsening symptoms to your healthcare provider immediately, especially if they relate to your lungs, eyes, skin, liver, kidneys, heart, or bleeding. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. Adtrinib Tablet should not be stopped without first talking to your doctor. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping Adtrinib Tablet. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately.